<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05025345</url>
  </required_header>
  <id_info>
    <org_study_id>EMON-101-EHCE</org_study_id>
    <nct_id>NCT05025345</nct_id>
  </id_info>
  <brief_title>Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses</brief_title>
  <official_title>Clinical Evaluation of the Vision Performance of TECNIS EYHANCE™ Intraocular Lenses With TECNIS SIMPLICITY™ as Compared to TECNIS® 1-piece Intraocular Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Surgical Vision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Surgical Vision, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a 6-month, prospective, multicenter, bilateral, randomized subject- and&#xD;
      evaluator-masked, clinical investigation of the TECNIS Eyhance IOL versus the TECNIS 1-piece&#xD;
      IOL.&#xD;
&#xD;
      The study will be conducted at up to 15 sites in the U.S.A and will enroll approximately 220&#xD;
      subjects to achieve approximately 200 randomized and bilaterally implanted subjects,&#xD;
      resulting in approximately 100 evaluable subjects in each lens group at 6 months. Subjects&#xD;
      are to be implanted with the same IOL in both eyes: TECNIS Eyhance IOL or the TECNIS 1-Piece&#xD;
      IOL. The eye implanted first will be considered the primary study eye.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance-corrected Intermediate Visual Acuity at 66 cm (DCVA66)</measure>
    <time_frame>6 months postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best-corrected Distance Visual Acuity (BCDVA)</measure>
    <time_frame>6 months postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distance-corrected Intermediate Visual Acuity at 50 cm (DCVA50)</measure>
    <time_frame>6 months postoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Study Lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tecnis Eyhance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tecnis 1 piece IOL (Intraocular lens)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tecnis Eyhance</intervention_name>
    <description>Investigational intraocular lens replaces the natural lens removed during cataract surgery in both eyes.</description>
    <arm_group_label>Study Lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tecnis 1 piece IOL</intervention_name>
    <description>Control intraocular lens replaces the natural lens removed during cataract surgery in both eyes.</description>
    <arm_group_label>Control Lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Minimum 22 years of age&#xD;
&#xD;
          -  Bilateral cataracts for which posterior chamber IOL implantation has been planned&#xD;
&#xD;
          -  Preoperative best corrected distance visual acuity (BCDVA) of 20/40 Snellen or worse&#xD;
             with or without a glare source&#xD;
&#xD;
          -  Potential for postoperative best corrected visual acuity of 20/30 Snellen or better&#xD;
&#xD;
          -  Corneal astigmatism parameters:&#xD;
&#xD;
               -  Normal corneal topography and no irregular corneal astigmatism&#xD;
&#xD;
               -  Postoperative astigmatism can be surgically managed to be less than 1 D in each&#xD;
                  eye&#xD;
&#xD;
          -  Clear intraocular media other than cataract in each eye&#xD;
&#xD;
          -  Availability, willingness, ability, and sufficient cognitive awareness to comply with&#xD;
             examination procedures and study visits&#xD;
&#xD;
          -  Signed informed consent and HIPAA authorization or equivalent documentation necessary&#xD;
             to comply with applicable privacy laws pertaining to medical treatment in the&#xD;
             governing countries&#xD;
&#xD;
          -  Ability to understand and respond to a questionnaire in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any conditions or circumstances, including those specified in the TECNIS Eyhance™ IOL&#xD;
             Directions for Use, that, in the opinion of the investigator, may increase risk over&#xD;
             benefit or result in an adverse event during the study.&#xD;
&#xD;
          -  Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus,&#xD;
             nystagmus, etc.)&#xD;
&#xD;
          -  Concurrent participation or participation within 60 days prior to preoperative visit&#xD;
             in any other clinical trial&#xD;
&#xD;
          -  Desire for monovision correction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johnson &amp; Johnson Surgical Vision Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>Johnson &amp; Johnson Surgical Vision</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Contact</last_name>
    <phone>+1 714 7218682</phone>
    <email>apolicas@ITS.JNJ.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Empire Eye &amp; Laser Center</name>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southern California Eye Physicians and Associates</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center For Sight</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jones Eye Clinic</name>
      <address>
        <city>Sioux City</city>
        <state>Iowa</state>
        <zip>51104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chesapeake Eye Care &amp; Laser Center</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tekwani Vision Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Scott &amp; Christie and Associates, PC</name>
      <address>
        <city>Cranberry Township</city>
        <state>Pennsylvania</state>
        <zip>16606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Eye Care Specialists</name>
      <address>
        <city>Kingston</city>
        <state>Pennsylvania</state>
        <zip>18704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Key-Whitman Eye Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Berkeley Eye Institute, P.A.</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Whitsett Vision Group</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77055</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Focal Point Vision</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Parkhurst NuVision</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>R &amp; R Eye Research, LLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 26, 2021</study_first_submitted>
  <study_first_submitted_qc>August 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Devices Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA project site at http://yoda.yale.edu</ipd_description>
    <ipd_url>http://yoda.yale.edu</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

